Company Adds Tom Moore as Chief Commercial
Officer and Sandeep
Yadav as Chief Financial Officer
TEMPE, Ariz.,
June 20,
2024 /PRNewswire/ -- GT Medical Technologies, Inc.
(GT MedTech), a medical device company with a corporate purpose of
improving the lives of patients with brain tumors, today announced
two significant additions to its leadership team: Tom Moore as Chief Commercial Officer and
Sandeep Yadav as Chief Financial
Officer.
The appointments come at a critical time for GT MedTech as the
company accelerates the expansion of GammaTile®, the
only FDA-cleared revolutionary innovation in brain brachytherapy,
across the United States to more
centers and institutions.
"We're thrilled to add two well-respected leaders with Tom and
Sandeep to our senior leadership team," said Per Langoe, CEO of GT
MedTech. "Tom's ability to develop effective commercial strategies
will help accelerate the adoption of GammaTile across the country,
while Sandeep's expertise in our industry will ensure the company's
financial health and continued growth."
Moore brings more than two decades of experience in healthcare
having led sales and marketing efforts for seven novel therapies in
the U.S. and Europe. Moore's
Medtech career began at Medtronic where he held leadership roles in
sales and marketing. Prior to joining GT MedTech, he was on
the executive leadership teams at CVRx and Ablative Solutions.
"GammaTile has one of the most compelling stories for its impact
on patients suffering from new and recurrent brain tumors," Moore
said. "I look forward to working closely with the leadership team
to bring GammaTile to reach its full potential as we expand our
reach beyond the more than 1,400 patients already treated."
With over two decades of experience in finance, data analytics,
operations, and strategic leadership, Yadav will lead GT MedTech's
financial operations. Yadav has held senior roles at
CardioMEMS, Qardio, Profusa, and Cardian, where he led
transformative initiatives including implementing advanced data
analytics, enhancing accounting systems, and securing significant
investments.
"I am thrilled to join GT Medical Technologies at this pivotal
moment in its journey. The innovative work being done with
GammaTile has the potential to revolutionize the treatment of brain
tumors and significantly improve patient outcomes," Yadav said. "I
am excited to work with the talented professionals at GT Medical
Technologies to drive our mission forward and achieve
groundbreaking advancements in medical technology."
About GT Medical Technologies, Inc.
Driven to raise the standard of care and improve the lives of
patients with brain tumors, a team of brain tumor specialists
formed GT Medical Technologies. GammaTile® is
FDA-cleared as a treatment for patients with newly diagnosed
malignant intracranial neoplasms and patients with recurrent
intracranial neoplasms. Since its full market release in
the United States in March 2020, GammaTile has been offered in over
100 leading institutions, with more centers being added each month.
For more information, visit www.gtmedtech.com and follow @GammaTile
on Twitter and LinkedIn.
Media Contacts:
Lori Kagan
GT Medical Technologies
lkagan@gtmedtech.com
Dawn Fallon
New Dawn Communications
dfallon@newdawncomms.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/gt-medical-technologies-inc-appoints-two-industry-medical-device-veterans-to-key-leadership-positions-302177418.html
SOURCE GT Medical Technologies